UNITEDHEALTH GROUP INC·4

Mar 19, 4:33 PM ET

DeVeydt Wayne S 4

4 · UNITEDHEALTH GROUP INC · Filed Mar 19, 2026

Research Summary

AI-generated summary of this filing

Updated

UnitedHealth (UNH) CFO Wayne DeVeydt Receives Award

What Happened
Wayne S. DeVeydt, Chief Financial Officer of UnitedHealth Group (UNH), was credited with 149.989 shares on 2026-03-17 as an award/acquisition (reported on Form 4 filed 2026-03-19). The filing shows a reported price of $0.00 for the grant (listed as dividend equivalents on outstanding restricted stock units), so the transaction is recorded with no cash purchase or sale.

Key Details

  • Transaction date: 2026-03-17; filing date: 2026-03-19.
  • Transaction type/code: Award/Acquisition (A).
  • Shares involved: 149.989 shares; reported price: $0.00 (total value shown as $0 on the form).
  • Shares owned after transaction: not specified in the provided data.
  • Footnote: These are dividend equivalents paid on outstanding restricted stock units and are subject to the same terms as the underlying RSUs; they are forfeited if the underlying units do not vest (footnote F1).
  • Timeliness: Filed two days after the transaction date (appears timely).

Context
This is a compensation-related credit (dividend equivalents on RSUs), not an open-market purchase or sale. Such awards are routine for executives and depend on vesting conditions of the underlying RSUs, so they don't necessarily signal a buying or selling intent.

Insider Transaction Report

Form 4
Period: 2026-03-17
DeVeydt Wayne S
Chief Financial Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-17+149.98919,666.93 total
Footnotes (1)
  • [F1]Represents dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if such units do not vest.
Signature
Faraz A. Choudhry, Attorney-in-Fact for Wayne S. DeVeydt|2026-03-19

Documents

1 file
  • 4
    wk-form4_1773952435.xmlPrimary

    FORM 4